186 related articles for article (PubMed ID: 11845114)
21. Vascular retention of Tc-99m pertechnetate and Tc-99m sestamibi, mimicking thyroid carcinoma metastases.
Tuncel M; Ozgen Kiratli P
Rev Esp Med Nucl; 2007; 26(4):226-9. PubMed ID: 17662189
[No Abstract] [Full Text] [Related]
22. Cutaneous metastasis from follicular carcinoma of the thyroid gland.
Caron P; Moreau-Cabarrot A; Gorguet B; Bazex J
Thyroid; 1993; 3(3):235-7. PubMed ID: 8257865
[TBL] [Abstract][Full Text] [Related]
23. Clinical management and outcome of papillary and follicular (differentiated) thyroid cancer presenting with distant metastasis at diagnosis.
Sampson E; Brierley JD; Le LW; Rotstein L; Tsang RW
Cancer; 2007 Oct; 110(7):1451-6. PubMed ID: 17705176
[TBL] [Abstract][Full Text] [Related]
24. Management of thyroid cancer of follicular cell origin: Gundersen/Lutheran Medical Center, 1969-1995.
Martins RG; Caplan RH; Lambert PJ; Rooney B; Kisken WA
J Am Coll Surg; 1997 Oct; 185(4):388-97. PubMed ID: 9328388
[TBL] [Abstract][Full Text] [Related]
25. Thyroglobulin and low-dose iodine-131 and technetium-99m-tetrofosmin whole-body scintigraphy in differentiated thyroid carcinoma.
Gallowitsch HJ; Mikosch P; Kresnik E; Unterweger O; Gomez I; Lind P
J Nucl Med; 1998 May; 39(5):870-5. PubMed ID: 9591591
[TBL] [Abstract][Full Text] [Related]
26. [Coincidence of unifocal thyroid autonomy and follicular carcinoma. Case report].
Einert A; Blattmann H; Reinhardt M; Moser E
Radiologe; 1995 Aug; 35(8):531-4. PubMed ID: 7568800
[TBL] [Abstract][Full Text] [Related]
27. Occurrence of papillary carcinoma in a hyperfunctioning thyroid nodule: report of a case and diagnostic considerations.
Castelli V; Moscogiuri D; Taviani AP; Donati L
Thyroidology; 1994 Aug; 6(2):69-72. PubMed ID: 7536453
[TBL] [Abstract][Full Text] [Related]
28. [Radioiodine in the treatment of generalized papillary and follicular thyroid carcinoma].
Mäenpää H
Duodecim; 2014; 130(6):573-9. PubMed ID: 24724456
[TBL] [Abstract][Full Text] [Related]
29. Metastatic differentiated thyroid carcinoma: clinicopathological profile and outcome in an iodine deficient area.
Mishra A; Mishra SK; Agarwal A; Das BK; Agarwal G; Gambhir S
World J Surg; 2002 Feb; 26(2):153-7. PubMed ID: 11865341
[TBL] [Abstract][Full Text] [Related]
30. Investigation of thyroid nodules using technetium-99m sestamibi.
Sundram FX; Mack PO
Ann Acad Med Singap; 1993 Jul; 22(4):560-2. PubMed ID: 8257058
[No Abstract] [Full Text] [Related]
31. [Multi-modality therapy concept in metastatic follicular thyroid carcinoma with hyperthyroidism].
Brauckhoff M; Dorsch K; Hädecke J; Kujat C; Straube F; Krause U; Dralle H
Chirurg; 2001 Jan; 72(1):37-42. PubMed ID: 11225454
[TBL] [Abstract][Full Text] [Related]
32. Follow-up of differentiated thyroid cancer.
Pacini F
Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S492-6. PubMed ID: 12192551
[TBL] [Abstract][Full Text] [Related]
33. [Patients treated for differentiated thyroid cancer with negative 131I whole-body scans and elevated thyroglobulin levels: a possible course].
Gutiérrez Cardo AL; Rodríguez Rodríguez JR; Borrego Dorado I; Navarro González E; Tirado Hospital JL; Vázquez Albertino R
Rev Esp Med Nucl; 2007; 26(3):138-45. PubMed ID: 17524307
[TBL] [Abstract][Full Text] [Related]
34. Sensitivity of 123I whole-body scan and thyroglobulin in the detection of metastases or recurrent differentiated thyroid cancer.
de Geus-Oei LF; Oei HY; Hennemann G; Krenning EP
Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):768-74. PubMed ID: 12029550
[TBL] [Abstract][Full Text] [Related]
35. The role of total thyroidectomy in the management of differentiated thyroid cancer.
Stephenson BM; Wheeler MH; Clark OH
Curr Opin Gen Surg; 1994; ():53-9. PubMed ID: 7584009
[TBL] [Abstract][Full Text] [Related]
36. Multifocal hyperfunctioning thyroid carcinoma without metastases.
Nishida AT; Hirano S; Asato R; Tanaka S; Kitani Y; Honda N; Fujiki N; Miyata K; Fukushima H; Ito J
Auris Nasus Larynx; 2008 Sep; 35(3):432-6. PubMed ID: 17826928
[TBL] [Abstract][Full Text] [Related]
37. Accumulation of technetium-99m pertechnetate in a patient with metastases of thyroid carcinoma.
Yamamoto Y; Nishiyama Y; Ono Y; Satoh K; Ohkawa M; Kawasaki Y; Tanabe M
Ann Nucl Med; 1999 Oct; 13(5):357-9. PubMed ID: 10582808
[TBL] [Abstract][Full Text] [Related]
38. Delayed radioiodine organification in Plummer's disease.
Intenzo CM; Park CH; Kim SM
Clin Nucl Med; 1995 Mar; 20(3):203-5. PubMed ID: 7750210
[TBL] [Abstract][Full Text] [Related]
39. Radioiodine therapy for papillary and follicular thyroid carcinoma.
Klain M; Ricard M; Leboulleux S; Baudin E; Schlumberger M
Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S479-85. PubMed ID: 12192549
[TBL] [Abstract][Full Text] [Related]
40. Thallium-201 scintigraphy to predict therapeutic outcome of iodine-131 therapy of metastatic thyroid carcinoma.
Nakada K; Katoh C; Kanegae K; Tsukamoto E; Shiga T; Mochizuki T; Itoh K; Tamaki N
J Nucl Med; 1998 May; 39(5):807-10. PubMed ID: 9591580
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
